Level Four Advisory Services’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-1,904
Closed -$786K 652
2021
Q3
$786K Sell
1,904
-272
-13% -$113K 0.08% 213
2021
Q2
$805K Buy
2,176
+128
+6% +$42.7K 0.06% 302
2021
Q1
$594K Buy
+2,048
New +$569K 0.05% 354

Other funds holding CRL

Level Four Advisory Services's CRL Position: Q4 2021 in Review

Level Four Advisory Services sold out of Charles River Laboratories (CRL) in Q4 2021, closing a stake of 1,904 shares — an estimated $786K sold.

Level Four Advisory Services first reported a position in CRL in Q1 2021 and held it in 3 quarters. The position peaked at $805K in Q2 2021. 707 funds tracked by Wall St. Rank hold CRL as of Q4 2021.

  • Level Four Advisory Services reported no remaining Charles River Laboratories position as of Q4 2021 after selling out during the quarter.
  • Level Four Advisory Services sold 1,904 Charles River Laboratories shares in Q4 2021, an estimated $786K.
  • Level Four Advisory Services first reported a position in Charles River Laboratories in Q1 2021 and held it in 3 quarters.
  • Level Four Advisory Services's Charles River Laboratories position peaked at $805K in Q2 2021.
  • 707 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2021.

Based on Level Four Advisory Services's 13F filing for Q4 2021, filed 11 Feb 2022.